Sennosides Capsule, Liquid Filled
NDC Package 69848-016-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sennosides capsules is sennosides are used to treat constipation. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Granules Usa Inc, this product is identified by NDC 69848-016 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
69848-016-10
Package Description
100 CAPSULE, LIQUID FILLED in 1 BOTTLE
Product Code
69848-016
11-Digit Billing Format
69848001610
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sennosides
Non-Proprietary Name
Sennosides
Substance Name
Sennosides
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES 17.2 mg/17.21
Usage Information
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

Regulatory & Marketing

Labeler Name
Granules Usa Inc
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-29-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69848-016-10 identifies a specific commercial package of 100 capsule, liquid filled in 1 bottle of Sennosides, a human over the counter drug labeled by Granules Usa Inc. This capsule, liquid filled is formulated for oral use and contains sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Granules Usa Inc on May 29, 2020. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

How is this Granules Usa Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69848001610. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69848-016-10
11-Digit CMS (5-4-2)
69848-0016-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.